TimesSquare Capital Management LLC lessened its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 12.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 298,860 shares of the business services provider's stock after selling 43,990 shares during the period. TimesSquare Capital Management LLC owned approximately 0.59% of Exponent worth $24,226,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Exponent by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider's stock valued at $476,284,000 after acquiring an additional 67,296 shares during the period. Geode Capital Management LLC grew its position in Exponent by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 1,519,584 shares of the business services provider's stock valued at $135,419,000 after acquiring an additional 13,932 shares during the period. Invesco Ltd. lifted its stake in shares of Exponent by 1.1% during the fourth quarter. Invesco Ltd. now owns 1,188,373 shares of the business services provider's stock worth $105,884,000 after purchasing an additional 13,263 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Exponent by 7.4% during the fourth quarter. Northern Trust Corp now owns 770,270 shares of the business services provider's stock worth $68,631,000 after purchasing an additional 53,227 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Exponent by 0.6% during the fourth quarter. Wells Fargo & Company MN now owns 739,710 shares of the business services provider's stock worth $65,908,000 after purchasing an additional 4,704 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Trading Up 2.0%
Shares of EXPO traded up $1.44 during midday trading on Thursday, reaching $74.36. 77,739 shares of the company were exchanged, compared to its average volume of 262,525. The stock has a 50-day moving average price of $76.40 and a 200-day moving average price of $81.78. The company has a market cap of $3.77 billion, a price-to-earnings ratio of 36.23 and a beta of 0.90. Exponent, Inc. has a 1-year low of $71.72 and a 1-year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The company had revenue of $137.44 million for the quarter, compared to analysts' expectations of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The firm's quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.59 earnings per share. Equities research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.61%. The ex-dividend date was Friday, June 6th. Exponent's dividend payout ratio (DPR) is 58.54%.
Insider Buying and Selling
In related news, VP John Pye sold 2,000 shares of the business's stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president owned 29,204 shares in the company, valued at approximately $2,228,849.28. The trade was a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Bradley A. James sold 2,694 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total value of $214,226.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is currently owned by corporate insiders.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.